251 related articles for article (PubMed ID: 3102504)
41. Plasminogen activator inhibitor type-1 protein, mRNA and gene transcription are increased by phorbol esters in human rhabdomyosarcoma cells.
Mayer M; Lund LR; Riccio A; Skouv J; Nielsen LS; Stacey SN; Danø K; Andreasen PA
J Biol Chem; 1988 Oct; 263(30):15688-93. PubMed ID: 3262618
[TBL] [Abstract][Full Text] [Related]
42. Cells of the human myelomonocytic line RC-2A synthesize tissue factor-like procoagulant and urokinase-type plasminogen activator.
Karhumäki E; Saravo L; Helin H
J Leukoc Biol; 1987 Jul; 42(1):36-42. PubMed ID: 3298513
[TBL] [Abstract][Full Text] [Related]
43. Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines.
Georg B; Helseth E; Lund LR; Skandsen T; Riccio A; Danø K; Unsgaard G; Andreasen PA
Mol Cell Endocrinol; 1989 Jan; 61(1):87-96. PubMed ID: 2501120
[TBL] [Abstract][Full Text] [Related]
44. Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells.
Pöllänen J; Saksela O; Salonen EM; Andreasen P; Nielsen L; Danø K; Vaheri A
J Cell Biol; 1987 Apr; 104(4):1085-96. PubMed ID: 3104349
[TBL] [Abstract][Full Text] [Related]
45. Expression of urokinase plasminogen activator receptor in resting and activated bovine neutrophils.
Politis I; Zavizjon B; Cheli F; Baldi A
J Dairy Res; 2002 May; 69(2):195-204. PubMed ID: 12222798
[TBL] [Abstract][Full Text] [Related]
46. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
47. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
48. Cell- and gene-specific interactions between signal transduction pathways revealed by okadaic acid. Studies on the plasminogen activating system.
Medcalf RL
J Biol Chem; 1992 Jun; 267(17):12220-6. PubMed ID: 1318313
[TBL] [Abstract][Full Text] [Related]
49. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.
Pepper MS; Belin D; Montesano R; Orci L; Vassalli JD
J Cell Biol; 1990 Aug; 111(2):743-55. PubMed ID: 1696269
[TBL] [Abstract][Full Text] [Related]
50. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.
Andreasen PA; Nielsen LS; Kristensen P; Grøndahl-Hansen J; Skriver L; Danø K
J Biol Chem; 1986 Jun; 261(17):7644-51. PubMed ID: 3086313
[TBL] [Abstract][Full Text] [Related]
51. Induction of plasminogen activator inhibitor 1 biosynthesis by hyperthermia.
Bergonzelli GE; Kruithof EK
J Cell Physiol; 1991 Aug; 148(2):306-13. PubMed ID: 1652590
[TBL] [Abstract][Full Text] [Related]
52. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
Lawrence D; Strandberg L; Grundström T; Ny T
Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
[TBL] [Abstract][Full Text] [Related]
53. Differences between the F10, BL6 and F1 sublines of the B16 melanoma in the enhancement of plasminogen activator and plasminogen activator inhibitor secretion by phorbol myristate acetate.
Hart DA; Smith R
Cancer Lett; 1987 Apr; 35(1):27-38. PubMed ID: 3105864
[TBL] [Abstract][Full Text] [Related]
54. Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states.
Kruithof EK; Gudinchet A; Bachmann F
Thromb Haemost; 1988 Feb; 59(1):7-12. PubMed ID: 3129809
[TBL] [Abstract][Full Text] [Related]
55. cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta.
Ye RD; Wun TC; Sadler JE
J Biol Chem; 1987 Mar; 262(8):3718-25. PubMed ID: 3029122
[TBL] [Abstract][Full Text] [Related]
56. Synthesis of urokinase-type plasminogen activator and of type-1 plasminogen activator inhibitor in neuronal cultures of human fetal brain: stimulation by phorbol ester.
Presta M; Ennas MG; Torelli S; Ragnotti G; Gremo F
J Neurochem; 1990 Nov; 55(5):1647-54. PubMed ID: 2213017
[TBL] [Abstract][Full Text] [Related]
57. Phorbol ester and mitogens stimulate human fibroblast secretions of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin.
Eaton DL; Baker JB
J Cell Biol; 1983 Aug; 97(2):323-8. PubMed ID: 6224800
[TBL] [Abstract][Full Text] [Related]
58. Functional characteristics of receptor-bound urokinase on human monocytes: catalytic efficiency and susceptibility to inactivation by plasminogen activator inhibitors.
Kirchheimer JC; Remold HG
Blood; 1989 Sep; 74(4):1396-402. PubMed ID: 2548640
[TBL] [Abstract][Full Text] [Related]
59. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
de Bart AC; Quax PH; Löwik CW; Verheijen JH
J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
[TBL] [Abstract][Full Text] [Related]
60. Detection of both type 1 and type 2 plasminogen activator inhibitors in human cells.
Schleef RR; Wagner NV; Loskutoff DJ
J Cell Physiol; 1988 Feb; 134(2):269-74. PubMed ID: 3257967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
